CHENG-MAW HOREY-HENG HU2020-02-112020-02-1120190003-4932https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075115382&doi=10.1097%2fSLA.0000000000003244&partnerID=40&md5=2ca9cc47c2a9c4a65b383b185374217bhttps://scholars.lib.ntu.edu.tw/handle/123456789/457738[SDGs]SDG3alpha fetoprotein; alpha fetoprotein blood level; California; cancer classification; cancer patient; demography; human; Letter; liver cell carcinoma; liver transplantation; New York; practice guideline; priority journal; liver transplantation; liver tumor; patient selection; time factor; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Liver Transplantation; Patient Selection; Time Factorsletter10.1097/SLA.0000000000003244317266232-s2.0-85075115382